Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Atopic Dermatitis”

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05676242
What this trial is testing

A Phase III Extended Clinical Trial of Jaktinib Hydrochloride Tablets in the Treatment of Moderate and Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 400
Testing effectiveness (Phase 2)Looking for participantsNCT06397911
What this trial is testing

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Oneness Biotech Co., Ltd. 114
Not applicableStudy completedNCT05989932
What this trial is testing

Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA)

Who this might be right for
Atopic Dermatitis
Societa Italiana di Dermatologia Medica, Chirurgica, Estetica e di Malattie Sessualmente Trasmesse 146
Post-approval studies (Phase 4)Study completedNCT02300701
What this trial is testing

Role of Anti-IgE in Severe Childhood Eczema

Who this might be right for
Atopic EczemaAtopic DermatitisChild
Guy's and St Thomas' NHS Foundation Trust 62
Not applicableEnded earlyNCT02634905
What this trial is testing

Randomized Control Trial in Children With Moderate to Severe Atopic Dermatitis to Assess the Benefit of a Nurse-led One-to-one Education Program in Addition to Standard Care Compared to Standard Care Alone on the Long Term Control of Disease Severity at 6 Months

Who this might be right for
Dermatitis, Atopic
Nantes University Hospital 178
Testing effectiveness (Phase 2)Study completedNCT06713499
What this trial is testing

A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Children and Adolescents With Moderate-to-severe Atopic Dermatitis
Guangdong Hengrui Pharmaceutical Co., Ltd 51
Testing effectiveness (Phase 2)Looking for participantsNCT06947980
What this trial is testing

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Keymed Biosciences Co.Ltd 200
Large-scale testing (Phase 3)Looking for participantsNCT06311682
What this trial is testing

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
LEO Pharma 195
Large-scale testing (Phase 3)Study completedNCT03334396
What this trial is testing

Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Eli Lilly and Company 660
Testing effectiveness (Phase 2)Study completedNCT02347176
What this trial is testing

Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
MedImmune LLC 204
Large-scale testing (Phase 3)Looking for participantsNCT06723080
What this trial is testing

Phase III Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Moderate to Severe Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 480
Not applicableNot Yet RecruitingNCT04730024
What this trial is testing

Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Who this might be right for
Atopic Dermatitis
Kang Stem Biotech Co., Ltd. 102
Not applicableStudy completedNCT07577921
What this trial is testing

Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments

Who this might be right for
Atopic Dermatitis
Pierre Fabre Dermo Cosmetique 80
Early research (Phase 1)Study completedNCT04090229
What this trial is testing

A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
ASLAN Pharmaceuticals 52
Testing effectiveness (Phase 2)Study completedNCT05432596
What this trial is testing

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Aclaris Therapeutics, Inc. 250
Large-scale testing (Phase 3)UnknownNCT06383468
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Akeso 420
Testing effectiveness (Phase 2)Study completedNCT06085521
What this trial is testing

LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Lynk Pharmaceuticals Co., Ltd 150
Large-scale testing (Phase 3)Active Not RecruitingNCT06552520
What this trial is testing

To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 500
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06158490
What this trial is testing

Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Who this might be right for
Moderate-to-severe Atopic Dermatitis
Guangzhou JOYO Pharma Co., Ltd 120
Testing effectiveness (Phase 2)Ended earlyNCT03517566
What this trial is testing

Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Novartis Pharmaceuticals 293
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation